Agboola S, McNeill A, Coleman T, Leonardi Bee J (2010) A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers. Addiction 105(8):1362–1380
CrossRefPubMedAmerican Psychiatric Association (APA) (2013) Diagnostic and statistical manual of mental disorders, 5. Aufl. American Psychiatric Publishing, Arlington
Andreas S, Batra A, Behr J, Chenot JF, Gillissen A, Hering T, Herth FJ, Kreuter M, Meierjürgen R, Mühlig S, Nowak D, Pfeifer M, Raupach T, Schultz K, Sitter H, Walther JW, Worth H (2014) Smoking cessation in patients with COPD. Pneumologie 68:237–258
CrossRefPubMedArzneimittelkommission der Deutschen Ärzteschaft (2010) Therapieempfehlungen Tabakabhängigkeit. Arzneiverordnungen in der Praxis, 2. Aufl. Berlin
Barnes J, Dong CY, McRobbie H, Walker N et al (2010) Hypnotherapy for smoking cessation. Cochrane Database Syst Rev (10). CD001008
Batra A (2000) Tabakabhängigkeit und Raucherentwöhnung bei psychiatrischen Patienten. Fortschr Neurol Psychiatr 68:80–92
CrossRefPubMedBatra A, Buchkremer G (2004) Tabakabhängigkeit – Ein Leitfaden für Therapeuten. Kohlhammer, Stuttgart
Batra A, Hoch E, Mann KL, Petersen KU (Hrsg) (2015) S3-Leitlinie Screening, Diagnose und Behandlung des schädlichen und abhängigen Tabakkonsums. Springer, Heidelberg
Cahill K, Stead LF, Lancaster T (2013) Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev (6). CD009329
Chiba M, Masironi R (1992) Toxic and trace elements in tobacco and tobacco smoke. Bull World Health Organ 70:269–275
PubMedPubMedCentralCritchley JA, Capewell S (2003) Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 290:86–97
CrossRefPubMedDilling H, Mombour W, Schmidt MH (Hrsg) (2010). Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F). Klinisch-diagnostische Leitlinien. 7. revidierte Fassung. Huber, Bern
Doll R, Peto R, Boreham J et al (2004) Mortality in relation to smoking: 50 years observations on male British doctors. Br Med J 328:1519
CrossRefFagerström K (2012) Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res 14:75–8
CrossRefPubMedFiore MC, Jaén CR, Baker T et al (2008) Treating tobacco use and dependence: update. U.S. Department of Health and Human Services. Public Health Services, Rockville MD
Fowler CD, Arends MA, Kenny PJ (2008) Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice. Behav Pharmacol 19:461–484
CrossRefPubMedPubMedCentralHeatherton TF, Kozlowski LT, Frecker RC, Fagerström KO (1991) The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 86:1119–1127
CrossRefPubMedHeinz A, Batra A, Scherbau N, Gouzoulis-Mayfrank E (2012) Neurobiologie der Abhängigkeit. Kohlhammer, Stuttgart
Hoch E, Mühlig S, Häfler M et al (2004) How prevalent is smoking and nicotine dependence in primary care in Germany? Addiction 99:1586–1598
CrossRefPubMedHughes JR, Hatsukami DK (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289–294
CrossRefPubMedHughes JR, Helzer JE, Lindberg S (2006) Prevalence of DSM/ICD-defined nicotine dependence. Drug Alcohol Depend 85(2):91–102
CrossRefPubMedHughes JR, Stead LF, HartmannBoyce J, Cahill K, Lancaster T (2014) Antidepressants for smoking cessation. Cochrane Database Syst Rev (1). CD000031
Kaper J, Wagena M, Willemsen MC, Van Schayck CP (2006) A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence. Addiction 101(Suppl 11):1656–1661
CrossRefPubMedLancaster T, Stead LF (2005) Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev (4). CD001118
Lindson-Hawley N, Thompson TP, Begh R (2015) Motivational interviewing for smoking cessation. Cochrane Database Syst Rev (3). CD006936
Miller WR, Rollnick S (2015) Motivierende Gesprächsführung, 3. Aufl. Lambertus, Freiburg i. Breisg
Neubauer S, Welte R, Beiche A et al (2006) Morbidity and costs attributable to smoking in Germany: update and a 10-year comparison. Tob Control 15:464–471
CrossRefPubMedPubMedCentralPapke RL, Dwoskin LP, Crooks PA (2007) The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery. J Neurochem 101:160–167
CrossRefPubMedPeto R, Lopez AD, Boreham J, Thun M (2006) Mortality from smoking in developed countries 1950–2000. University of Oxford Clinical Trial Service Unit.
http://www.ctsu.ox.ac.uk/~tobacco/. Zugegriffen am 20.11.2015
Prochaska JO, DiClemente CC (1983) Stages and processes of self-change of smoking: towards an integrative model of change. J Consult Clin Psychol 51:390–395
CrossRefPubMedRüther T, Bobes J, De Hert M et al (2014) EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. Eur Psychiatry 29(2):65–82
CrossRefPubMedSchumann A, Rumpf H-J, Meyer C et al (2003) Deutsche Version des Fagerström Test for Nicotine Dependence (FTND-G) und des Heaviness of Smoking Index (HSI-G). In: Glöckner-Rist A, Rist F, Küfner H (Hrsg) Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES) Version 300. Zentrum für Umfragen, Methoden und Analysen, Mannheim
Statistisches Bundesamt (2014) Fragen zur Gesundheit 2013. Metzler-Pöschel, Stuttgart
Statistisches Bundesamt (Hrsg) (2015) Absatz von Tabakwaren 2014. Fachserie 14: Finanzen und Steuern, Reihe 9.1.1, Statistisches Bundesamt, Wiesbaden
Stead LF, Lancaster T (2005) Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev (2). CD001007
Stead LF, Perera R, Bullen C, Mant D et al (2012) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev (11). CD009670
Stead LF, Buitrago D, Preciado N, Sanchez G et al (2013) Physician advice for smoking cessation. Cochrane Database Syst Rev Cochrane Tob Addict Group Cochrane Database Syst Rev (5). CD000165
Takada-Takatori Y, Kume T et al (2009) Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation. Biol Pharm Bull 32:318–324
CrossRefPubMedTutka P, Mosiewicz J, Wielosz M (2005) Pharmacokinetics and metabolism of nicotine. Pharmacol Rep 57:143–153
PubMedWatkins SS, Koob GF, Markou A (2000) Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res 2:19–38
CrossRefPubMedWest R (2005) Time for change: putting the Transtheoretical (Stages of Change) Model to rest. Addiction 100:1036–1040
CrossRefPubMedWhite AR, Rampes H, Liu PJ, Stead LF, Campbell J (2014) Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev (1). CD000009
World Health Organization (2009) WHO report on the global tobacco epidemic. WHO Press, Genf